Burdens of Malignant Melanoma and Projections for 2050 in Asia: Findings from the 2023 Global Burden of Disease Study
Asia faces a dual challenge: rising incidence and a progressive eastward/southward burden shift to lower‑SDI countries; effective responses require equitable, context-specific strategies combining sun‑safety campaigns, early detection, advanced diagnostics, and affordable treatments across socioeconomic strata.